[Studies on the use of BP400 Sandoz in allergic dermatoses].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use*; D013997:Time Factors; D014970:Xanthines / Q000627:therapeutic use*
D010880:Piperidines; D014970:Xanthines
Badania nad zastosowaniem preparatu BP-4-- sandoz w dermatozach alergicznych.